ID: ALA719179
Type: Functional
Description: Intraperitoneal effective dose required for inhibition of apomorphine-induced climbing in mice
Bioactivity
Activity Types for Assay ALA719179
ED50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
326.83 | 3.72 | 3.72 |
375.87 | 4.43 | 4.43 |
410.49 | 3.59 | 3.59 |
435.63 | 4.64 | 4.64 |
502.73 | 5.77 | 5.77 |
494.68 | 5.37 | 5.37 |
375.58 | 3.52 | 3.52 |
405.61 | 3.69 | 3.69 |
337.46 | 2.26 | 2.26 |
353.92 | 2.78 | 2.78 |
376.55 | 2.73 | 2.73 |
381.97 | 3.55 | 3.55 |
367.95 | 3.16 | 3.16 |
353.92 | 2.78 | 2.78 |
398.58 | 3.45 | 3.45 |
353.92 | 2.78 | 2.78 |
444.67 | 4.43 | 4.43 |
370.52 | 2.67 | 2.67 |
494.68 | 5.37 | 5.37 |
476.69 | 5.23 | 5.23 |
480.65 | 4.98 | 4.98 |
404.61 | 3.51 | 3.51 |
376.55 | 2.73 | 2.73 |
462.64 | 2.38 | 2.38 |
398.58 | 3.45 | 3.45 |
452.09 | 5.16 | 5.16 |
404.61 | 3.51 | 3.51 |
462.66 | 4.84 | 4.84 |
479.12 | 5.09 | 5.09 |
421.61 | 4.25 | 4.25 |
377.55 | 2.91 | 2.91 |
403.59 | 3.44 | 3.44 |
349.50 | 2.13 | 2.13 |
415.53 | 3.92 | 3.92 |
377.55 | 2.91 | 2.91 |
430.64 | 4.04 | 4.04 |
363.53 | 2.52 | 2.52 |
387.47 | 3.14 | 3.14 |
393.62 | 3.62 | 3.62 |
444.67 | 4.43 | 4.43 |
451.63 | 3.62 | 3.62 |
443.68 | 5.04 | 5.04 |
461.67 | 5.18 | 5.18 |
478.13 | 5.69 | 5.69 |
429.66 | 4.65 | 4.65 |
520.72 | 5.91 | 5.91 |
502.73 | 5.77 | 5.77 |
478.69 | 4.27 | 4.27 |
404.61 | 3.51 | 3.51 |
434.63 | 2.87 | 2.87 |
458.58 | 4.05 | 4.05 |
432.66 | 4.29 | 4.29 |
453.08 | 4.55 | 4.55 |
347.53 | 2.74 | 2.74 |
361.56 | 3.21 | 3.21 |
418.63 | 3.90 | 3.90 |
390.58 | 3.12 | 3.12 |
389.61 | 3.99 | 3.99 |
361.56 | 3.21 | 3.21 |
333.50 | 2.43 | 2.43 |
361.56 | 3.21 | 3.21 |
415.53 | 3.92 | 3.92 |
333.50 | 2.43 | 2.43 |